SCHEMBL23043472

SCHEMBL23043472

CCOP(=O)(COC[C@H]1O[C@@H](c2cnc3c(N(C(=O)OC(C)(C)C)C4CCCC4)ncnn23)[C@@H]2OC(C)(C)O[C@@H]21)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23052687 0.83 — —
SCHEMBL23052610 0.81 NT5E (0.36) —
SCHEMBL23042861 0.71 ALDH1A1 (0.30) —
SCHEMBL23042952 0.69 GPR119 (0.33) —
SCHEMBL22899715 0.69 NT5E (0.32) —
SCHEMBL29613885 0.69 NT5E (0.32) —
SCHEMBL22899656 0.68 NT5E (0.33) —
SCHEMBL22899496 0.67 NT5E (0.33) —
SCHEMBL29613801 0.67 NT5E (0.33) —
SCHEMBL29613863 0.67 NT5E (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021040356-A1 C-NUCLEOSIDES, C-NUCLEOTIDES AND THEIR ANALOGS, EQUIVALENTS AND PRODRUGS THEREOF FOR ECTONUCLEOTIDASE INHIBITION KAINOS MEDICINE, INC. (KR) 2021-03-04 — — WO disclosed
WO-2021040356-A1 C-NUCLEOSIDES, C-NUCLEOTIDES AND THEIR ANALOGS, EQUIVALENTS AND PRODRUGS THEREOF FOR ECTONUCLEOTIDASE INHIBITION KAINOS MEDICINE, INC. (KR) 2021-03-04 — — WO disclosed
Send feedback